O2–04–05: Reducing endogenous tau prevents APP/Aβ–induced deficits in a mouse model of Alzheimer's disease
Erik D. Roberson(University of Alabama at Birmingham), Lennart Mucke(Gladstone Institutes), Kimberly Scearce‐Levie, Fengrong Yan(Gladstone Institutes), Gui-Qiu Yu(Gladstone Institutes)
Cited by 0
Related Papers
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
|Journal of Neuroscience|2000|1.9k
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease
|Neuron|2007|1.7k
Network abnormalities and interneuron dysfunction in Alzheimer disease
|Nature reviews. Neuroscience|2016|1k
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
|Cold Spring Harbor Perspectives in Medicine|2012|1k